Mode of action of a soluble immune response suppressor (SIRS) produced by concanavalin a-activated spleen cells.
D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D002450:Cell Communication / Q000187:drug effects*; D003208:Concanavalin A; D004912:Erythrocytes / Q000276:immunology; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology*; D008297:Male; D051379:Mice; D013601:T-Lymphocytes / Q000276:immunology*
D000941:Antigens; D003208:Concanavalin A